Jon Skarstein

585 total citations
7 papers, 473 citations indexed

About

Jon Skarstein is a scholar working on Oncology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jon Skarstein has authored 7 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pharmacology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jon Skarstein's work include Cancer survivorship and care (4 papers), Treatment of Major Depression (3 papers) and Cancer-related cognitive impairment studies (2 papers). Jon Skarstein is often cited by papers focused on Cancer survivorship and care (4 papers), Treatment of Major Depression (3 papers) and Cancer-related cognitive impairment studies (2 papers). Jon Skarstein collaborates with scholars based in Norway and Finland. Jon Skarstein's co-authors include Sophie D. Fosså, Alv A. Dahl, Nina Aass, Eva Skovlund, Esa Leìnonen, K. Behnke, Hans �gren, Tone Rustøen, Torbjørn Moum and Ingvar Bjelland and has published in prestigious journals such as Journal of Psychosomatic Research, Journal of Pain and Symptom Management and European Neuropsychopharmacology.

In The Last Decade

Jon Skarstein

7 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Skarstein Norway 6 222 134 108 103 95 7 473
Gee Su Yang United States 11 164 0.7× 100 0.7× 63 0.6× 103 1.0× 82 0.9× 17 533
Elizabeth Holtsclaw United States 8 258 1.2× 210 1.6× 106 1.0× 31 0.3× 100 1.1× 11 556
Antonella Ciaramella Italy 10 130 0.6× 89 0.7× 55 0.5× 76 0.7× 113 1.2× 36 403
Maja Johannsen Denmark 18 306 1.4× 117 0.9× 204 1.9× 56 0.5× 61 0.6× 24 1.1k
Annie Gauvain‐Piquard France 10 276 1.2× 317 2.4× 106 1.0× 48 0.5× 78 0.8× 22 662
Haldun Soygür Türkiye 12 278 1.3× 132 1.0× 110 1.0× 25 0.2× 111 1.2× 25 652
Hannah M. Fisher United States 11 304 1.4× 201 1.5× 95 0.9× 42 0.4× 59 0.6× 38 596
Elvan Özalp Türkiye 9 276 1.2× 126 0.9× 100 0.9× 20 0.2× 79 0.8× 19 549
Fremonta Meyer United States 12 122 0.5× 152 1.1× 233 2.2× 153 1.5× 85 0.9× 34 659
P. Saltel France 10 289 1.3× 167 1.2× 157 1.5× 34 0.3× 43 0.5× 41 550

Countries citing papers authored by Jon Skarstein

Since Specialization
Citations

This map shows the geographic impact of Jon Skarstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Skarstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Skarstein more than expected).

Fields of papers citing papers by Jon Skarstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Skarstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Skarstein. The network helps show where Jon Skarstein may publish in the future.

Co-authorship network of co-authors of Jon Skarstein

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Skarstein. A scholar is included among the top collaborators of Jon Skarstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Skarstein. Jon Skarstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Skarstein, Jon, et al.. (2005). Is there an association between haemoglobin, depression, and anxiety in cancer patients?. Journal of Psychosomatic Research. 58(6). 477–483. 15 indexed citations
2.
Rustøen, Tone, Sophie D. Fosså, Jon Skarstein, & Torbjørn Moum. (2003). The impact of demographic and disease-specific variables on pain in cancer patients. Journal of Pain and Symptom Management. 26(2). 696–704. 50 indexed citations
3.
Skarstein, Jon, et al.. (2002). 'Patient Satisfaction' in Hospitalized Cancer Patients. Acta Oncologica. 41(7-8). 639–645. 32 indexed citations
4.
Skarstein, Jon, Nina Aass, Sophie D. Fosså, Eva Skovlund, & Alv A. Dahl. (2000). Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. Journal of Psychosomatic Research. 49(1). 27–34. 250 indexed citations
5.
Leìnonen, Esa, et al.. (2000). Mirtazapine has similar long-term efficacy and tolerability to citalopram and faster onset of action in the treatment of major depression. European Neuropsychopharmacology. 10. 265–265. 2 indexed citations
6.
Leìnonen, Esa, et al.. (1999). Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. International Clinical Psychopharmacology. 14(6). 329–337. 117 indexed citations
7.
Ågren, Hans, et al.. (1999). Efficacy and tolerability of mirtazapine vs citalopram: A double-blind, randomized study in patients with major depressive disorder. European Neuropsychopharmacology. 9. 228–229. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026